As of November 2024 Theravance Biopharma has a market cap of $0.43 Billion USD. This makes Theravance Biopharma the world's 6894th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 12th, 2024 the market cap of Theravance Biopharma was reported to be: